455 related articles for article (PubMed ID: 26281826)
1. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
[TBL] [Abstract][Full Text] [Related]
2. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
[TBL] [Abstract][Full Text] [Related]
3. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
Minatel E; Trovo M; Polesel J; Baresic T; Bearz A; Franchin G; Gobitti C; Rumeileh IA; Drigo A; Fontana P; Pagan V; Trovo MG
Lung Cancer; 2014 Jan; 83(1):78-82. PubMed ID: 24216141
[TBL] [Abstract][Full Text] [Related]
4. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.
Rosenzweig KE; Zauderer MG; Laser B; Krug LM; Yorke E; Sima CS; Rimner A; Flores R; Rusch V
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1278-83. PubMed ID: 22607910
[TBL] [Abstract][Full Text] [Related]
5. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.
Rimner A; Spratt DE; Zauderer MG; Rosenzweig KE; Wu AJ; Foster A; Yorke ED; Adusumilli P; Rusch VW; Krug LM
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):394-401. PubMed ID: 25073664
[TBL] [Abstract][Full Text] [Related]
6. Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.
Rimner A; Zauderer MG; Gomez DR; Adusumilli PS; Parhar PK; Wu AJ; Woo KM; Shen R; Ginsberg MS; Yorke ED; Rice DC; Tsao AS; Rosenzweig KE; Rusch VW; Krug LM
J Clin Oncol; 2016 Aug; 34(23):2761-8. PubMed ID: 27325859
[TBL] [Abstract][Full Text] [Related]
7. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
[TBL] [Abstract][Full Text] [Related]
8. Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
Fodor A; Broggi S; Incerti E; Dell'Oca I; Fiorino C; Samanes Gajate AM; Pasetti M; Cattaneo MG; Passoni P; Gianolli L; Calandrino R; Picchio M; Di Muzio N
Clin Lung Cancer; 2019 Jan; 20(1):e29-e38. PubMed ID: 30253920
[TBL] [Abstract][Full Text] [Related]
9. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.
Minatel E; Trovo M; Polesel J; Rumeileh IA; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Drigo A; Dassie A; Pagan V; Trovo MG
J Thorac Oncol; 2012 Dec; 7(12):1862-1866. PubMed ID: 23154558
[TBL] [Abstract][Full Text] [Related]
10. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
[TBL] [Abstract][Full Text] [Related]
11. Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesothelioma.
Arrieta O; Lozano-Ruiz F; Blake-Cerda M; Catalán R; Lara-Mejía L; Salinas MÁ; Maldonado-Magos F; Corona-Cruz JF
Thorac Cancer; 2020 Dec; 11(12):3448-3455. PubMed ID: 33030313
[TBL] [Abstract][Full Text] [Related]
12. Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.
Trovo M; Franceschini D; Furlan C; Pietrobon F; Vagge S; Farina E; Revelant A; Visani L; Maragna V; Parisi G; Scotti V
Radiol Med; 2019 Sep; 124(9):854-859. PubMed ID: 30963379
[TBL] [Abstract][Full Text] [Related]
13. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
[TBL] [Abstract][Full Text] [Related]
14. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
[TBL] [Abstract][Full Text] [Related]
15. Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review.
Patel R; Ludmir EB; Miccio JA; Menon H; Barsky AR; Mesko SM; Kodali M; Lautenschlaeger T; Adeberg S; Simone CB; Verma V
Pract Radiat Oncol; 2020; 10(6):423-433. PubMed ID: 32088429
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
17. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
18. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.
Friedberg JS; Simone CB; Culligan MJ; Barsky AR; Doucette A; McNulty S; Hahn SM; Alley E; Sterman DH; Glatstein E; Cengel KA
Ann Thorac Surg; 2017 Mar; 103(3):912-919. PubMed ID: 27825687
[TBL] [Abstract][Full Text] [Related]
19. Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience.
Franceschini D; De Rose F; Cozzi S; Renna I; Franzese C; Di Brina L; Navarria P; D'Agostino GR; Mancosu P; Tomatis S; Scorsetti M
Clin Lung Cancer; 2020 Jan; 21(1):86-93. PubMed ID: 31563545
[TBL] [Abstract][Full Text] [Related]
20. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]